first case of mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal...

2
1 2 Case Report 3 First case of Mediterranean spotted fever-associated rhabdomyolysis 4 leading to fatal acute renal failure and encephalitis 5 Claudia Colomba Q1 *, Claudia Imburgia, Marcello Trizzino, Lucina Titone 6 Dipartimento di Scienze per la Promozione della Salute e Materno Infantile G. D’Alessandro, Sezione di Malattie Infettive, Universita ` di Palermo, 7 Via del Vespro 129, Palermo, Italy 8 9 1. Introduction 10 Mediterranean spotted fever (MSF) is a tick-borne zoonosis. The 11 etiological agent is Rickettsia conorii, an obligate intracellular 12 Gram-negative, rod-shaped bacterium. In Italy, about 400 cases are 13 reported every year and nearly half of them occur in Sicily, which is 14 one of the most endemic regions. 1 15 Although MSF is mostly a self-limited disease characterized by 16 fever, skin rash, and a dark eschar at the site of the tick bite called a 17 ‘tache noire’, serious complications are described, mainly in adult 18 patients. 1,2 Diagnosis is based on epidemiological, clinical, and 19 laboratory criteria. Concerning therapy, doxycycline is considered 20 the safest and most efficacious treatment; clarithromycin is 21 considered a valid alternative, especially in patients with 22 hypersensitivity to tetracyclines, in pregnant women, and in 23 children. 3,4 24 We report a fatal case of MSF complicated by rhabdomyolysis, 25 acute renal failure, and encephalitis. 26 2. Case report 27 A 78-year-old woman was admitted to the Infectious Diseases 28 Unit of the University Hospital of Palermo, Italy, in August 2013, 29 because of clinical symptoms of continuous–remittent fever (max 30 38.5 8C), generalized rash, acute renal failure, and progressive loss 31 of consciousness over 48 h. Her medical history was significant for 32 type II diabetes mellitus and arterial hypertension. The patient also 33 had a history of acute myocardial infarction and ischemic stroke. 34 On admission the patient was in a serious clinical condition 35 with neurological impairment. Her Glasgow Coma Scale (GCS) 36 score was 3. Her body temperature was 38 8C, blood pressure 37 was 90/50 mmHg, and she presented an arrhythmic pulse at 38 a high frequency (heart rate 128 beats/min) and an oxygen 39 saturation of 97%. 40 On physical examination, she presented a general maculo- 41 papular rash with rare petechial elements that involved the palms 42 of the hands and the soles of the feet. Furthermore we noticed two 43 dark crusted lesions with a diameter of 50 mm like a ‘tache noire’ 44 on the left thigh. On chest auscultation the patient had normal 45 vesicular breathing sounds. Cardiac auscultation detected an 46 arrhythmic pulse and there was evidence of atrial fibrillation 47 on electrocardiogram. Abdominal examination revealed just 48 hepatomegaly. International Journal of Infectious Diseases xxx (2014) e1–e2 A R T I C L E I N F O Article history: Received 7 November 2013 Received in revised form 26 December 2013 Accepted 24 January 2014 Corresponding Editor: Eskild Petersen, Aarhus, Denmark Keywords: Mediterranean spotted fever Rickettsia conorii Rhabdomyolysis Acute renal failure Encephalitis S U M M A R Y Mediterranean spotted fever (MSF) is a tick-borne zoonosis caused by Rickettsia conorii. In Italy, about 400 cases are reported every year and nearly half of them occur in Sicily, which is one of the most endemic regions. Although MSF is mostly a self-limited disease characterized by fever, skin rash, and a dark eschar at the site of the tick bite called a ‘tache noire’, serious complications are described, mainly in adult patients. Nevertheless, severe forms of the disease with major morbidity and a higher mortality risk have been described. We report a fatal case of MSF complicated by rhabdomyolysis, acute renal failure, and encephalitis in an elderly woman. ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by- nc-sa/3.0/). * Corresponding author. Tel.: +39 091 655 4054; fax: +39 091 655 4059. E-mail address: [email protected] (C. Colomba). G Model IJID 1913 1–2 Please cite this article in press as: Colomba C, et al. First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis. Int J Infect Dis (2014), http://dx.doi.org/10.1016/j.ijid.2014.01.024 Contents lists available at ScienceDirect International Journal of Infectious Diseases jou r nal h o mep ag e: w ww .elsevier .co m /loc ate/ijid http://dx.doi.org/10.1016/j.ijid.2014.01.024 1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).

Upload: lucina

Post on 30-Dec-2016

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis

12

3

4

5 Q1

6

7

89

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

International Journal of Infectious Diseases xxx (2014) e1–e2

G Model

IJID 1913 1–2

Case Report

First case of Mediterranean spotted fever-associated rhabdomyolysisleading to fatal acute renal failure and encephalitis

Claudia Colomba *, Claudia Imburgia, Marcello Trizzino, Lucina Titone

Dipartimento di Scienze per la Promozione della Salute e Materno Infantile G. D’Alessandro, Sezione di Malattie Infettive, Universita di Palermo,

Via del Vespro 129, Palermo, Italy

A R T I C L E I N F O

Article history:

Received 7 November 2013

Received in revised form 26 December 2013

Accepted 24 January 2014

Corresponding Editor: Eskild Petersen,

Aarhus, Denmark

Keywords:

Mediterranean spotted fever

Rickettsia conorii

Rhabdomyolysis

Acute renal failure

Encephalitis

S U M M A R Y

Mediterranean spotted fever (MSF) is a tick-borne zoonosis caused by Rickettsia conorii. In Italy, about

400 cases are reported every year and nearly half of them occur in Sicily, which is one of the most

endemic regions. Although MSF is mostly a self-limited disease characterized by fever, skin rash, and a

dark eschar at the site of the tick bite called a ‘tache noire’, serious complications are described, mainly in

adult patients. Nevertheless, severe forms of the disease with major morbidity and a higher mortality

risk have been described. We report a fatal case of MSF complicated by rhabdomyolysis, acute renal

failure, and encephalitis in an elderly woman.

� 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-

nc-sa/3.0/).

Contents lists available at ScienceDirect

International Journal of Infectious Diseases

jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id

26

27282930313233343536373839404142

1. Introduction

Mediterranean spotted fever (MSF) is a tick-borne zoonosis. Theetiological agent is Rickettsia conorii, an obligate intracellularGram-negative, rod-shaped bacterium. In Italy, about 400 cases arereported every year and nearly half of them occur in Sicily, which isone of the most endemic regions.1

Although MSF is mostly a self-limited disease characterized byfever, skin rash, and a dark eschar at the site of the tick bite called a‘tache noire’, serious complications are described, mainly in adultpatients.1,2 Diagnosis is based on epidemiological, clinical, andlaboratory criteria. Concerning therapy, doxycycline is consideredthe safest and most efficacious treatment; clarithromycin isconsidered a valid alternative, especially in patients withhypersensitivity to tetracyclines, in pregnant women, and inchildren.3,4

We report a fatal case of MSF complicated by rhabdomyolysis,acute renal failure, and encephalitis.

434445464748

* Corresponding author. Tel.: +39 091 655 4054; fax: +39 091 655 4059.

E-mail address: [email protected] (C. Colomba).

Please cite this article in press as: Colomba C, et al. First case of Mediteacute renal failure and encephalitis. Int J Infect Dis (2014), http://dx

http://dx.doi.org/10.1016/j.ijid.2014.01.024

1201-9712/� 2014 The Authors. Published by Elsevier Ltd on behalf of International So

license (http://creativecommons.org/licenses/by-nc-sa/3.0/).

2. Case report

A 78-year-old woman was admitted to the Infectious DiseasesUnit of the University Hospital of Palermo, Italy, in August 2013,because of clinical symptoms of continuous–remittent fever (max38.5 8C), generalized rash, acute renal failure, and progressive lossof consciousness over 48 h. Her medical history was significant fortype II diabetes mellitus and arterial hypertension. The patient alsohad a history of acute myocardial infarction and ischemic stroke.

On admission the patient was in a serious clinical conditionwith neurological impairment. Her Glasgow Coma Scale (GCS)score was 3. Her body temperature was 38 8C, blood pressurewas 90/50 mmHg, and she presented an arrhythmic pulse ata high frequency (heart rate 128 beats/min) and an oxygensaturation of 97%.

On physical examination, she presented a general maculo-papular rash with rare petechial elements that involved the palmsof the hands and the soles of the feet. Furthermore we noticed twodark crusted lesions with a diameter of 50 mm like a ‘tache noire’on the left thigh. On chest auscultation the patient had normalvesicular breathing sounds. Cardiac auscultation detected anarrhythmic pulse and there was evidence of atrial fibrillationon electrocardiogram. Abdominal examination revealed justhepatomegaly.

rranean spotted fever-associated rhabdomyolysis leading to fatal.doi.org/10.1016/j.ijid.2014.01.024

ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA

Page 2: First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis

49

50 ceQ2

51 ne52 3.53 cr54 el55 1756 de57 in58 th59 >

60

61 af62 As63 do64 flu65 an66 re67

68 vi69 Ri70 de71 (IF72 w73 (IF74

75 ch76 tio77 Th78 in79 Be80 se81 th82 th83 ar

84 3.

85

86 fo87 ris88 ric89

90 in91 or92 co93 du94 th95

96 se97 m98 dy99 st100 an101 di102 in103 in104 hi

105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134

135

136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168

C. Colomba et al. / International Journal of Infectious Diseases xxx (2014) e1–e2e2

G Model

IJID 1913 1–2

Laboratory tests showed neutrophil leukocytosis (white bloodll (WBC) count 12.04 � 109/l with 87.4% polymorphonuclearutrophils), acute renal failure (uremia 216 mg/dl, creatinine

13 mg/dl, hyperkalemia, and hypoalbuminemia), increasedeatine kinase (>1400 U/l) and myoglobin (>2000 mg/dl),evated transaminase blood levels (aspartate aminotransferase6 U/l, alanine aminotransferase 79 U/l), increased lactatehydrogenase (LDH; 1041 U/l) and D-dimer (8238 ng/ml), anternational normalized ratio (INR) of 0.9, activated partialromboplastin time (APTT) of 33 s, and C-reactive protein27 mg/dl.

Brain computed tomography (CT) scans taken at admission andter 48 h were normal. A chest and abdomen CT scan was normal.

meningoencephalitis was suspected, a lumbar puncture wasne on the first day of admission and revealed clear cerebrospinalid (CSF) with a normal liquor tension, containing 5 � 106 WBC/l,

elevated sugar content of 96 mg/dl, and negative Pandyaction.

Routine microbiological cultures and PCR for herpes simplexrus from the CSF were negative, as were two blood culture sets.ckettsia PCRs on blood and CSF were negative. Serological tests totect R. conorii IgM and IgG (indirect immunofluorescence assayI) and ELISA) gave negative results. The R. conorii IFI and ELISA

ere repeated after 1 week, showing elevated IgM and IgG titersI IgM–IgG 1/320–1/640; ELISA IgM–IgG 1/200–1/800).Empiric antibiotic therapy was started with intravenous (IV)

loramphenicol and IV levofloxacin. After 3 days of hospitaliza-n the fever disappeared and the maculopapular rash improved.erapy with corticosteroids and mannitol was started with an

itial slight improvement revealed by neurological examination.cause of the progressive acute renal failure, hemodialysisssions were initiated in agreement with the nephrologist. One fifth day of hospitalization her clinical condition worsened ande patient died after 10 days of hospitalization due to cardiacrest during a hemodialysis session.

Discussion

Most cases of MSF follow a benign course. However, severerms of the disease with major morbidity and a higher mortalityk have been described.1,2,5 Few cases of spotted feverkettsiosis have been reported in HIV-positive patients.6

The pathogenesis of MSF complications results from vascularjury, which may be responsible for organ dysfunction of differentgans. Renal impairment has been described frequently as ansequence of severe MSF. Several mechanisms of renal damagering MSF have been reported and the prognosis is determined bye type of renal disease and by early treatment.7

Rhabdomyolysis is a syndrome characterized by elevatedrum concentrations of creatine phosphokinase (CPK) andyoglobin, as well as myoglobinuria, which can lead to renalsfunction. There are several causes of rhabdomyolysis: the use of

atins, trauma, prolonged immobilization, infection, electrolyted endocrine abnormalities, and genetic or connective tissuesorders. A viral etiology is the most frequent among the possiblefectious causes.8 Benign acute myositis secondary to R. conorii

fection has been described in the literature, as well asstologically documented pictures of myositis, but no case of

Please cite this article in press as: Colomba C, et al. First case of Meditacute renal failure and encephalitis. Int J Infect Dis (2014), http://d

rhabdomyolysis in the course of MSF has been described.Rhabdomyolysis due to R. conorii infection linked with acute renalfailure has not been reported previously.

In our case report, the patient was not taking any drug or goingthrough any situation that could explain the appearance ofrhabdomyolysis.9 The exact pathogenesis of Rickettsia-inducedmyopathy remains unclear, but we are led to believe that R. conorii,like the influenza virus, may act by direct invasion and immune-mediated mechanisms.8

Neurological complications of MSF include clinical pictures ofmeningitis and meningoencephalitis.10,11 The pathogenetic mech-anism responsible for the brain damage is thought to be theinvasion and multiplication in vascular endothelial cells, resultingin widespread vasculitis of capillaries, arterioles, and smallarteries. Our patient had a clinical presentation of meningoen-cephalitis, but the chemical–physical characteristics of the CSF, aswell as the search for Rickettsia by PCR, were negative.

An early diagnosis and prompt initiation of antibiotic therapyare crucial to the outcome of the disease. Doxycycline is the goldstandard treatment for MSF in adults. In severe and complicatedcases, the use of high doses of doxycycline (200 mg twice daily) isreported to give good results, as well as the use of chloramphenicolin cases of neurological involvement.

Our case demonstrates the importance of recognizing rhabdo-myolysis as a complication of R. conorii infection and its potentialassociation with life-threatening acute renal failure and electrolyteimbalances. Furthermore we recommend close monitoring of CPKand symptoms of myopathy in all patients with MSF.

Conflict of interest: The authors declare that they have nocompeting interests or funding.

References

1. Colomba C, Saporito L, Polara VF, Rubino R, Titone L. Mediterranean spottedfever: clinical and laboratory characteristics of 415 Sicilian children. BMC InfectDis 2006;6:60.

2. Saporito L, Giammanco GM, Rubino R, Ingrassia D, Spicola D, Titone L, et al.Severe Mediterranean spotted fever complicated by acute renal failure andherpetic oesophagitis. J Med Microbiol 2010;59(Pt 8):990–2.

3. Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin versusazithromycin in the treatment of Mediterranean spotted fever in children: arandomized controlled trial. Clin Infect Dis 2002;34:154–8.

4. Cascio A, Colomba C, Di Rosa D, Salsa L, di Martino L, Titone L. Efficacy and safetyof clarithromycin as treatment for Mediterranean spotted fever in children: arandomized controlled trial. Clin Infect Dis 2001;33:409–11.

5. Colomba C, Saporito L, Colletti P, Mazzola G, Rubino R, Pampinella D, et al. Atrialfibrillation in Mediterranean spotted fever. J Med Microbiol 2008;57(Pt 11):1424–6.

6. Colomba C, Siracusa L, Madonia S, Saporito L, Bonura C, De Grazia S, et al. A caseof spotted fever rickettsiosis in a human immunodeficiency virus-positivepatient. J Med Microbiol 2013;62(Pt 9):1363–4.

7. Montasser DI, Zajjari Y, Alayoud A, Bahadi A, Aatif T, Hassani K, et al. Acute renalfailure as a complication of Mediterranean spotted fever. Nephrol Ther2011;7:245–7.

8. Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. Rhabdomyolysis associatedwith 2009 influenza A (H1N1). JAMA 2009;302:1863–4.

9. Colomba C, Rubino R, Siracusa L, Mazzola G, Titone L. Rhabdomyolysis associ-ated with the co-administration of daptomycin and pegylated interferon a-2band ribavirin in a patient with hepatitis C. J Antimicrob Chemother 2012;67:249–50.

10. Kularatne SA, Weerakoon KG, Rajapakse RP, Madagedara SC, Nanayakkara D,Premaratna R. A case series of spotted fever rickettsiosis with neurologicalmanifestations in Sri Lanka. Int J Infect Dis 2012;16:e514–7.

11. Duque V, Ventura C, Seixas D, Barai A, Mendonca N, Martins J, et al. Mediterra-nean spotted fever and encephalitis: a case report and review of the literature.J Infect Chemother 2012;18:105–8.

erranean spotted fever-associated rhabdomyolysis leading to fatalx.doi.org/10.1016/j.ijid.2014.01.024